DoubleChecks

What was claimed

Fenbendazole, the cheap animal dewormer, has been proven to treat 20 different types of cancer (brain, lung, breast, prostate, pancreatic and more) through at least 3 pathways with over 15 scientific publications confirming it. It's non-toxic, works with other treatments, but suppressed by Big Pharma because it can't be patented.

Our verdict

Inaccurate

Studies show fenbendazole has preclinical anti-tumor activity in various cancer cell lines and animal models, not proven treatment efficacy in humans. Major cancer organizations and oncology groups state there is no robust clinical evidence that fenbendazole is safe or effective for people with cancer. There are multiple scientific publications on fenbendazole’s anti-cancer effects in vitro and in vivo and on its mechanisms. But current literature does not include clinical trials confirming that fenbendazole treats cancer in humans, and leading oncology bodies explicitly note a lack of robust clinical evidence.

All 3 AI systems agree10 sources citedChecked Jul 13, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

There are over 15 scientific publications confirming that fenbendazole treats these cancers.

Incorrect90%
1 of 3 AIs agree·Claude: Can’t verify, ChatGPT: Misleading

Fenbendazole is non-toxic.

Incorrect90%
All 3 AIs agree

Fenbendazole, the cheap animal dewormer, has been proven to treat 20 different types of cancer (brain, lung, breast, prostate, pancreatic and more).

Incorrect95%
All 3 AIs agree

Fenbendazole works with other treatments.

Misleading78%
1 of 2 AIs agree·ChatGPT: Can’t verify

Fenbendazole treats cancer through at least 3 pathways.

Misleading83%
All 3 AIs agree

Fenbendazole is suppressed by Big Pharma because it can't be patented.

Can’t verify68%
2 of 3 AIs agree·Claude: Misleading

Verified against 10 sources

euclid.intar.iiarjournals.orgfrontiersin.orgpmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govtlcr.amegroups.orgyoutube.compure.johnshopkins.educancer.orgasco.org

Detailed Analysis

The response makes strong claims that fenbendazole has been proven to treat many human cancers and is being suppressed, which are not supported by current evidence. Existing data are mainly preclinical or anecdotal, and expert and cancer-agency sources explicitly state there is no proof of safety or efficacy in humans.

Why this verdict

  • The response makes strong claims that fenbendazole has been proven to treat many human cancers and is being suppressed, which are not supported by current evidence.
  • Existing data are mainly preclinical or anecdotal, and expert and cancer-agency sources explicitly state there is no proof of safety or efficacy in humans.

Claims checked

There are over 15 scientific publications confirming that fenbendazole treats these cancers.

Incorrect90%
There are multiple scientific publications on fenbendazole’s anti-cancer effects in vitro and in vivo and on its mechanisms.[1] [2] [3] [4] [5] [6] [7] [8] But current literature does not include clinical trials confirming that fenbendazole treats cancer in humans, and leading oncology bodies explicitly note a lack of robust clinical evidence.[9] [10]

This claim may mislead readers without added context.

Fenbendazole is non-toxic.

Incorrect90%
While fenbendazole has an acceptable safety profile as a veterinary antiparasitic at approved doses, intensive treatments show toxicity in cell and animal studies, and liver toxicity has been reported in some preclinical cancer contexts.[2] [4] [6] Expert and cancer-agency sources caution that safety in humans at cancer-treatment doses is unproven and potential risks exist.[1] [5] [9] [10]

This claim may mislead readers without added context.

Fenbendazole, the cheap animal dewormer, has been proven to treat 20 different types of cancer (brain, lung, breast, prostate, pancreatic and more).

Incorrect96%
Studies show fenbendazole has preclinical anti-tumor activity in various cancer cell lines and animal models, not proven treatment efficacy in humans.[1] [2] [3] [5] Major cancer organizations and oncology groups state there is no robust clinical evidence that fenbendazole is safe or effective for people with cancer.[9] [10]

This claim may mislead readers without added context.

What other AI think

The claim makes several false or highly misleading assertions about fenbendazole's proven efficacy against cancer. While preclinical research exists, there are zero human clinical trials proving fenbendazole treats any cancer type in humans. The "20 cancer types" and "15 scientific publications" claims are unsubstantiated, and the "non-toxic" claim contradicts documented cases of liver toxicity. The suppression narrative misrepresents how drug approval works.

Why this verdict

  • The claim makes several false or highly misleading assertions about fenbendazole's proven efficacy against cancer.
  • While preclinical research exists, there are zero human clinical trials proving fenbendazole treats any cancer type in humans.
  • The "20 cancer types" and "15 scientific publications" claims are unsubstantiated, and the "non-toxic" claim contradicts documented cases of liver toxicity.
  • The suppression narrative misrepresents how drug approval works.

Claims checked

It's non-toxic

Incorrect90%
Case reports document two cases where patients experienced drug-related hepatic dysfunction, and signals of potential liver toxicity and unknown interactions with targeted therapy, radiation therapy, or other cancer treatments require caution.

This claim may mislead readers without added context.

Fenbendazole has been proven to treat 20 different types of cancer

Incorrect95%
Clinical evidence supporting fenbendazole's use and efficacy in treating metastatic cancer is currently limited. The FDA has never approved fenbendazole for humans for any purpose, and experts agree that scientific data does not exist about whether fenbendazole is safe and effective for people. No human clinical trials have been conducted.

This claim may mislead readers without added context.

Suppressed by Big Pharma because it can't be patented

Misleading80%
The lack of FDA approval reflects the absence of clinical trials and financial incentive, not suppression. Fenbendazole is not FDA approved for cancer because there is no financial incentive to fund the huge human trials needed for approval—no patent, no sponsor, no big trials. This is a regulatory and economic issue, not evidence of suppression.

This claim may mislead readers without added context.

The overall statement contains multiple significant factual errors and misleading implications. Strong preclinical signals exist, but human efficacy, safety, and the other numerical claims are not supported by evidence.

Why this verdict

  • The overall statement contains multiple significant factual errors and misleading implications.
  • Strong preclinical signals exist, but human efficacy, safety, and the other numerical claims are not supported by evidence.

Claims checked

"It's non-toxic"

Incorrect90%
Fenbendazole has toxicity risks and case reports (including liver injury) exist; safety in humans has not been established for cancer dosing.

This claim may mislead readers without added context.

"Fenbendazole ... has been proven to treat 20 different types of cancer (brain, lung, breast, prostate, pancreatic and more)"

Incorrect95%
There is no clinical proof that fenbendazole cures or is a validated treatment for any cancer type in humans; only limited in vitro and animal studies exist for a few tumor models.

This claim may mislead readers without added context.

"through at least 3 pathways"

Misleading75%
Laboratory studies suggest mechanisms (e.g., microtubule disruption, metabolic effects, possible STAT3/tubulin interactions), but these are preclinical findings and do not prove therapeutic pathways in patients.

This claim may mislead readers without added context.

Share this result

Try DoubleChecks